Puromycin resistance gene (pac), provided in a pORF plasmid. pORF is an expression plasmid selectable with Ampicillin....
...
... loxP-PGK-gb2-neo-loxP template is designed to allow ... cells. The loxP-PGK-gb2-neo-loxP template encodes ... a prokaryotic promoter (gb2) for expression ... a eukaryotic promoter (PGK) for expression ...
... These precision 5mm diameter, 7 inch long PYREX ... for compatibility with ground joints, valves, and vacuum ... spectrometers running from 300 to 500MHz. They have ... I.D. of 4.20 + 0.013-0.000mm. These NMR tubes ...
Biology Products:... recent killer tsunami has highlighted once more the ... function is taken up by mangroves, forests thriving ... are ecologically and socio-economically important for local people ... geography, hydrology, socio-economic interviews, and 18th-century history, an ...
... growing older are as,inevitable and obvious as “going ... cause of this usually unwelcome transformation.,In a report ... journal Science,researchers from Dana-Farber Cancer Institute and Children’s ... of graying hair while,investigating the origins of malignant ...
... to fully understand a particular communication pathway inside of ... cancers. While scientists have identified elements of this pathway, ... Whitehead Institute now have discovered a missing puzzle piece, ... significant new cancer target. , "We believe that we ...
Other Biology News:Essential mangrove forest threatened by cryptic ecological degradation 2Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery 2Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery 3Researchers identify target for cancer drugs 2(Date:12/11/2009)... SAN DIEGO, Dec. 11 Ambit Biosciences Corporation ... of Texas M. D. Anderson Cancer Center of the ... 220 Monotherapy E fficacy) Phase 2 ... myeloid leukemia (AML). AC220 is a novel, orally ... specifically designed as a FMS-like tyrosine kinase-3 (FLT3) inhibitor. ...
(Date:12/11/2009)... December 11, 2009 -- Esco announces the opening of a NEW ... as a technical service, training and logistics center to support Esco,s ... New Product Introductions (NPI) for temperature-controlled laboratory equipment. , ... ... opening of a NEW 2nd North American facility in Marietta, OH. ...
(Date:12/10/2009)... With the economy and markets exhibiting continued ... fastest-growing small cap equity research provider, will seek to ... within the micro cap market at the firm,s ... 2010 at the Grand Hyatt Hotel in New York, ... and undervalued by much of Wall Street, but the ...
(Date:12/10/2009)... 10 Vivakor, Inc. (OTC Bulletin ... entered into an exclusive, $5 million license ... Inc. ( www.regeneca.com ). The agreement ... a new cutting-edge nutraceutical formulation developed by ... future formulations by Vivakor for Regeneca. Under ...
Breaking Biology Technology:Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5Technology, Biotech, Energy and Transportation Among the Industries to be Featured at Sidoti & Company's First Annual 2010 Micro Cap Conference 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 3Biology NavigationMedical Navigation